You are here

Article Text

Article menu

Download PDFPDF

XML
Guidelines
British Thoracic Society guideline for bronchiectasis in adults
  1. Adam T Hill1,
  2. Anita L Sullivan2,
  3. James D Chalmers3,
  4. Anthony De Soyza4,
  5. J Stuart Elborn5,
  6. R Andres Floto6,7,
  7. Lizzie Grillo8,
  8. Kevin Gruffydd-Jones9,
  9. Alex Harvey10,
  10. Charles S Haworth7,
  11. Edwin Hiscocks11,
  12. John R Hurst12,
  13. Christopher Johnson7,
  14. W Peter Kelleher13,14,15,
  15. Pallavi Bedi16,
  16. Karen Payne17,
  17. Hesham Saleh5,
  18. NIcholas J Screaton18,
  19. Maeve Smith19,
  20. Michael Tunney20,
  21. Deborah Whitters21,
  22. Robert Wilson14 and
  23. Michael R Loebinger14
  1. 1 Respiratory Medicine, Royal Infirmary of Edinburgh, and University of Edinburgh, Edinburgh, UK
  2. 2 Department of Respiratory Medicine, University Hospitals Birmingham NHS Foundation Trust (Queen Elizabeth Hospital), Birmingham, UK
  3. 3 Scottish Centre for Respiratory Research, University of Dundee, Ninewells Hospital, Dundee, UK, Dundee, UK
  4. 4 Institute of Cellular Medicine, NIHR Biomedical Research Centre for Aging and, Freeman Hospital Adult Bronchiectasis Service, Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, UK
  5. 5 Royal Brompton Hospital and Imperial College London, and Queens University Belfast, London, UK
  6. 6 Department of Medicine, University of Cambridge, Cambridge, UK
  7. 7 Cambridge Centre for Lung Infection, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK
  8. 8 Royal Brompton Hospital, London, UK
  9. 9 Box Surgery, Box, Wiltshire, UK
  10. 10 Department of Clinical Sciences, Brunel University, London, UK
  11. 11 Coventry, Coventry, UK
  12. 12 UCL Respiratory, University College London, London, UK
  13. 13 Centre for Immunology and Vaccinology, Chelsea and Westminster Hospital Campus, Imperial College London, London, UK
  14. 14 Host Defence Unit, Department of Respiratory Medicine, Royal Brompton and Harefield NHS Foundation Trust, London, UK
  15. 15 Chest and Allergy Clinic, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK
  16. 16 MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK
  17. 17 Glenfield Hospital, Leicester, UK
  18. 18 Department of Radiology, Royal Papworth Hospital, Cambridge, UK
  19. 19 University of Alberta, Edmonton, Canada
  20. 20 School of Pharmacy, Queens University, Belfast, UK
  21. 21 Queen Elizabeth University Hospital, Glasgow, UK
  1. Correspondence to Professor Adam T Hill; adam.hill318{at}nhs.net

Abstract

The full British Thoracic Society Guideline for Bronchiectasis in Adults is published in Thorax. The following is a summary of the recommendations and good practice points. The sections referred to in the summary refer to the full guideline. The appendices are available in the full guideline.

  • bronchiectasis

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

https://doi.org/10.1136/bmjresp-2018-000348

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors AH, AS and ML chaired the guideline group, and as lead author led the drafting and revision of the document. All authors drafted sections of the full guideline and undertook revisions of the paper. AH, AS and ML had final responsibility for the guideline and for the summary paper submitted to BMJORR.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests All authors have completed a declaration of interest form in line with BTS Policy and copies are available from BTS head office on request. JC has declared funding from Bayer Healthcare, Griffols, Pfizer, Insmed, Chiesi, Boehringer Ingelheim, GlaxoSmithkline, Astra Zeneca, Napp. ADS has declared funding from Bayer Healthcare, Pfizer, Insmed, Boehringer Ingelheim, Astra Zeneca. SE has declared funding from GlaxoSmithKline. AF has declared funding from GlaxoSmithKline, Zambon, Insmed, Verona. KGJ has declared funding from Boehringer Ingelheim, GlaxoSmithkline, Astra Zeneca, Napp, TEVA, Chiesi, Nutricia, Novartis. CSH has declared funding from Aradigm, Gilead, Griffols, Insmed, Chiesi, GlaxoSmithkline, TEVA, Vertex, Zambon, Novartis. ATH has declared funding from Bayer Healthcare, Boehringer Ingelheim. JRH has declared funding from Pfizer. MRL has declared funding from Bayer Healthcare, Insmed, Pulmocide, Griffols, Polyphor, Savara. MT has declared funding from Novartis, Basilea, Stragen. RW has declared funding from Bayer Healthcare.

    • Patient consent Not required.

    • Provenance and peer review Commissioned; internally peer reviewed.

    • Data sharing statement No additional data are available.